Clinical trialNCT05873712RecruitingPhase 2Interventional

Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

SponsorAseel AlsouqiEnrollment24Recurrent Transformed B-Cell Non-Hodgkin LymphomaRecurrent Transformed Chronic Lymphocytic LeukemiaRecurrent Transformed Non-Hodgkin LymphomaRefractory TransformedRefractory Transformed B-cell Non-Hodgkin LymphomaRefractory Transformed Chronic Lymphocytic Leukemia+2 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jennifer A Woyach, MD
Ohio State University Comprehensive Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Icahn School of Medicine at Mount Sinai
New York, New York, United States
Adam Kittai, MD
Recruiting
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Jennifer A Woyach, MD
Recruiting
Huntsman Cancer Institute
Salt Lake City, Utah, United States
Harsh Shah, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Jul 2023
Primary completion: 31 Dec 2026
Completion: 31 Dec 2026
Last update posted: 3 Mar 2026
Registered enrollment: 24
Registry id: NCT05873712

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.